News and Announcements

EQT not planning to bid for Oxford Biomedica

By Michele Maatouk

Date: Wednesday 25 Feb 2026

(Sharecast News) - Oxford Biomedica shares slumped on Wednesday after Swedish private equity firm EQT said it was not planning to make an offer for the gene and cell therapy company.
In a brief statement, it said: "EQT is appreciative of the engagement with OXB's board of directors and management team...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page